UBS Group AG

Holdings History for VYNE Therapeutics Inc. - Common Stock, par value $0.0001 per share (VYNE)

Symbol: VYNE on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$36,401	62,761	+57,189	+1026%	$0.58	Q4 2025
30 Sep 2025	0%	0%	$1,866	5,572	+5,572	NEW	$0.33	Q3 2025
30 Jun 2025		-0%	$0	0	-7,576	-100%	$0.56	Q2 2025
31 Mar 2025	0%	+0%	$11,970	7,576	+6,945	+1100%	$1.58	Q1 2025
31 Dec 2024	0%	0%	$2,114	631	+617	+4407%	$3.35	Q4 2024
30 Sep 2024	0%	-0%	$26	14	-25,044	-100%	$1.86	Q3 2024
30 Jun 2024	0%	+0%	$49,365	25,058	+25,042	+156512%	$1.97	Q2 2024
31 Mar 2024	0%	-0%	$49	16	-830	-98%	$3.06	Q1 2024
31 Dec 2023	0%	+0%	$1,972	846	+662	+360%	$2.33	Q4 2023
30 Sep 2023	0%	-0%	$744	184	-902	-83%	$4.04	Q3 2023
30 Jun 2023	0%	+0%	$4,452	1,086	+721	+198%	$4.10	Q2 2023
31 Mar 2023	0%	+0%	$1,124	365	+365	NEW	$3.08	Q1 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.